Diffuse large B cell lymphomas with a t(14;18) have an inferior outcome compared to bcl2 positive cases lacking the translocation.

被引：0
|
作者：
Barrans, SL
O'Connor, SJM
Owen, R
Haynes, AP
Morgan, GJ
Jack, AS
机构：
[1] Gen Infirm, HMDS, Acad Unit Haematolol Oncol, Leeds LS1 3EX, W Yorkshire, England
[2] City Hosp Nottingham, Nottingham, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1391
引用
收藏
页码：329A / 330A
页数：2
相关论文
共 50 条
  • [1] C-MYC and bCL2 translocation frequency in diffuse large B cell lymphomas
    Akkaya, H.
    Akkaya, B.
    Salim, O.
    Ozcan, M.
    Yucel, O. K.
    Erdem, R.
    Iltar, U.
    Undar, L.
    VIRCHOWS ARCHIV, 2015, 467 : S195 - S195
  • [2] C-MYC AND BCL2 TRANSLOCATION FREQUENCY IN DIFFUSE LARGE B CELL LYMPHOMAS
    Akkaya, B.
    Salim, O.
    Akkaya, H.
    Ozcan, M.
    Yucel, O. K.
    Erdem, R.
    Iltar, U.
    Undar, L.
    HAEMATOLOGICA, 2015, 100 : 395 - 395
  • [3] Translocation t(14;18) and gain of chromosome 18/BCL2:: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas
    Galteland, E
    Sivertsen, EA
    Svendsrud, DH
    Smedshammer, L
    Kresse, SH
    Meza-Zepeda, LA
    Myklebost, O
    Suo, Z
    Mu, D
    DeAngelis, PM
    Stokke, T
    LEUKEMIA, 2005, 19 (12) : 2313 - 2323
  • [4] Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas
    E Galteland
    E A Sivertsen
    D H Svendsrud
    L Smedshammer
    S H Kresse
    L A Meza-Zepeda
    O Myklebost
    Z Suo
    D Mu
    P M DeAngelis
    T Stokke
    Leukemia, 2005, 19 : 2313 - 2323
  • [5] Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody
    Masir, Noraidah
    Campbell, Lisa J.
    Jones, Margaret
    Mason, David Y.
    PATHOLOGY, 2010, 42 (03) : 212 - 216
  • [6] Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations
    Visco, Carlo
    Wang, Jinfen
    Tisi, Maria Chiara
    Deng, Lijuan
    D'Amore, Emanuele S. G.
    Tzankov, Alexandar
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Bhagat, Govind
    Hsi, Eric D.
    van Krieken, J. Han
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Moller, Michael B.
    Piris, Miguel A.
    Medeiros, L. Jeffrey
    Xu-Monette, Zijun Y.
    Young, Ken H.
    BRITISH JOURNAL OF CANCER, 2017, 117 (11) : 1685 - 1688
  • [7] Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations
    Carlo Visco
    Jinfen Wang
    Maria Chiara Tisi
    Lijuan Deng
    Emanuele S G D'Amore
    Alexandar Tzankov
    Santiago Montes-Moreno
    Karen Dybkær
    Govind Bhagat
    Eric D Hsi
    J Han van Krieken
    Maurilio Ponzoni
    Andrés J M Ferreri
    Michael B Møller
    Miguel A Piris
    L Jeffrey Medeiros
    Zijun Y Xu-Monette
    Ken H Young
    British Journal of Cancer, 2017, 117 : 1685 - 1688
  • [8] C-MYC and BCL2 translocation frequency in diffuse large B-cell lymphomas: A study of 97 patients
    Akkaya, Bahar
    Salim, Ozan
    Akkaya, Hampar
    Ozcan, Mualla
    Yucel, Orhan Kemal
    Erdem, Ramazan
    Iltar, Utku
    Undar, Levent
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2016, 59 (01) : 41 - 46
  • [9] Growing Importance of MYC/BCL2 Immunohistochemistry in Diffuse Large B-Cell Lymphomas
    Pfreundschuh, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) : 3433 - 3435
  • [10] BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphomas (DLBCL)
    Akyurek, N.
    Uner, A.
    Benekli, M.
    Barista, I.
    LABORATORY INVESTIGATION, 2010, 90 : 283A - 283A
12345